// App-Quantinova.ai

: Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.

Researchers

Presenter

  • Javier Puente

Principal Investigators

  • Alvaro Pinto

  • Maria Jose Mendez Vidal

  • Xavier Garcia del Muro

  • Pablo Maroto-Rey

  • Sergio Vazquez-Estevez

  • Raquel Luque

  • Urbano Anido

  • Torsten Strunz-McKendry

  • Anil Upadhyay

  • Jose Montes

  • Aurora Ortiz Nuñez

  • Judit González Portela

  • Daniel Castellano

Medical Centers

  • Effice Research, Madrid, Spain

  • Servicio de Medicina Nuclear, Hospital Universitario La Pax, Madrid, Spain

  • Servicio de Oncologia Medica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • ICO Institut Catala d'Oncologia, Barcelona, Spain

  • Hospital Universitario Virgen de las Nieves & Instituto de Investigación Biosanitaria IBS, Granada, Spain

  • Maimonides Institute for Biomedical research of Cordoba (IMIBIC) Hospital Universitario Reina Sofía, Córdoba, Spain

  • Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain

Locations

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Advanced Urothelial Carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved